BackDetection of Chromosomal Aberrations in Clinical Practice: From Karyotype to Genome Sequence
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Detection of Chromosomal Aberrations in Clinical Practice
Introduction to Chromosomal Aberrations
Chromosomal aberrations are structural or numerical changes in chromosomes that can lead to genetic disorders and diseases. The detection of these aberrations is a cornerstone of clinical genetics, with methods evolving from traditional karyotyping to advanced genome sequencing techniques.
Chromosomal Aberration: Any change in the normal structure or number of chromosomes, often resulting in disease or developmental issues.
Clinical Cytogenetics: The field focused on the study and diagnosis of chromosomal abnormalities in clinical settings.
Applications: Diagnosis of genetic syndromes, prenatal screening, cancer genetics, and research into genetic diseases.
Major Methods for Detecting Chromosomal Aberrations
Karyotyping
Karyotyping is the traditional method for visualizing chromosomes under a microscope, allowing for the detection of large-scale chromosomal abnormalities.
Definition: The process of pairing and ordering all the chromosomes of an organism, providing a genome-wide snapshot of an individual's chromosomes.
G-Banding: A staining technique (using Giemsa dye) that produces a characteristic pattern of light and dark bands on chromosomes, aiding in their identification and the detection of structural changes.
Limitations: Can only detect large chromosomal changes (typically >5-10 Mb); smaller deletions, duplications, or subtle rearrangements may go unnoticed.
Example: Detection of Down syndrome (trisomy 21) by identifying an extra copy of chromosome 21.
Fluorescence In Situ Hybridization (FISH)
FISH is a molecular cytogenetic technique that uses fluorescent probes to bind to specific DNA sequences on chromosomes, allowing for the detection of specific genetic abnormalities.
Definition: A technique that uses fluorescently labeled DNA probes to detect the presence or absence of specific DNA sequences on chromosomes.
Applications: Detection of microdeletions, duplications, and translocations that are too small to be seen by karyotyping.
Advantages: Higher resolution than karyotyping; can be used on non-dividing (interphase) cells.
Limitations: Targeted approach—only detects abnormalities where probes are designed to bind.
Example: Detection of the BCR-ABL fusion gene in chronic myeloid leukemia.
Comparative Genomic Hybridization (CGH) and Array CGH
CGH and its advanced form, array CGH, are molecular techniques for detecting copy number variations (CNVs) across the genome.
Comparative Genomic Hybridization (CGH): Compares the DNA of a test sample to a reference sample to identify gains or losses of chromosomal material.
Array CGH: Uses microarrays to provide higher resolution, allowing detection of much smaller CNVs than traditional CGH or karyotyping.
Applications: Diagnosis of developmental delay, intellectual disability, and congenital anomalies.
Limitations: Cannot detect balanced rearrangements (e.g., translocations or inversions) that do not change copy number.
Example: Detection of microdeletion syndromes such as DiGeorge syndrome (22q11.2 deletion).
Single Nucleotide Polymorphism (SNP) Arrays
SNP arrays are high-resolution tools that detect both copy number changes and regions of homozygosity, which can indicate uniparental disomy or consanguinity.
Definition: Microarrays that genotype hundreds of thousands of SNPs across the genome.
Applications: Detection of CNVs, loss of heterozygosity, and identification of regions inherited from a single parent.
Advantages: Provides both copy number and genotyping information.
Limitations: Like array CGH, cannot detect balanced rearrangements.
Next-Generation Sequencing (NGS)
NGS technologies allow for comprehensive analysis of the genome at single-nucleotide resolution, enabling the detection of a wide range of genetic variants.
Definition: High-throughput sequencing methods that can sequence entire genomes or targeted regions.
Applications: Detection of single nucleotide variants, small insertions/deletions, and structural variants.
Advantages: Highest resolution; can detect both balanced and unbalanced chromosomal changes.
Limitations: Higher cost, complexity, and data interpretation challenges compared to other methods.
Comparison of Chromosomal Aberration Detection Methods
Method | Resolution | Detects Balanced Rearrangements? | Detects CNVs? | Typical Applications |
|---|---|---|---|---|
Karyotyping (G-banding) | 5-10 Mb | Yes | Yes (large) | General chromosomal abnormalities, aneuploidies |
FISH | 100 kb - 1 Mb | Yes (if probe designed for breakpoint) | Yes (targeted) | Specific microdeletions, translocations |
Array CGH | 10-100 kb | No | Yes | Genome-wide CNV detection |
SNP Array | 10-100 kb | No | Yes | CNVs, uniparental disomy, consanguinity |
NGS | 1 bp | Yes | Yes | Comprehensive genome analysis |
Key Terms and Definitions
Copy Number Variation (CNV): A segment of DNA that varies in copy number between individuals, which can lead to genetic disorders.
Balanced Rearrangement: A chromosomal change where no genetic material is gained or lost (e.g., translocations, inversions).
Unbalanced Rearrangement: A chromosomal change resulting in extra or missing genetic material (e.g., deletions, duplications).
Aneuploidy: The presence of an abnormal number of chromosomes in a cell (e.g., trisomy 21).
Summary Table: Main Purposes of Detection Methods
Purpose | Best Method(s) |
|---|---|
Detect large chromosomal changes (aneuploidy, large deletions/duplications) | Karyotyping, FISH |
Detect microdeletions/microduplications | FISH, Array CGH, SNP Array |
Detect balanced rearrangements | Karyotyping, NGS |
Genome-wide high-resolution analysis | Array CGH, SNP Array, NGS |
Conclusion
The detection of chromosomal aberrations has evolved from low-resolution karyotyping to high-resolution genome sequencing. Each method has its strengths and limitations, and the choice of technique depends on the clinical question, required resolution, and available resources. Understanding these methods is essential for accurate diagnosis and management of genetic disorders.